CAR T Cell Therapy stands for Chimeric Antigen Receptor T Cell Therapy. It is a recombinant T cell-based anti-cancer treatment.
CAR T cell technology is an anti-cancer treatment that is seeing a rise in demand as it is seen as an alternative to chemotherapy and radiotherapy. The rising investment and research are also driving this therapy in the cancer treatment sector.
Regions of North America, especially the USA have seen tremendous growth in adoption and demand in the CAR T cell therapy market.
The global CAR-T cell therapy market size was estimated to be US$ 1.63 billion in 2021.
The global market for CAR-T cell therapy will most likely expand at over 15% CAGR between 2023 to 2032.
Based on indication, the CAR T cell therapy market is segmented into Acute Lymphocytic Leukaemia, Diffuse Large B-cell lymphoma, Mantle Cell Lymphoma, Follicular, Lymphoma, Multiple Myeloma and Others.
Copyright © 2024 Same Page Management Consulting Pvt. Ltd. (insightSLICE) | All Rights Reserved